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OBJECTIVES Athlete’s heart represents a structural and functional adaptation to regular endurance exercise.
BACKGROUND While left ventricular (LV) hypertrophy of the athlete’s heart has been examined in many
studies, the extent of right ventricular (RV) hypertrophy is still uncertain because of its
complex shape and trabecular structure. To examine RV hypertrophy, we used magnetic
resonance imaging (MRI) and hypothesized that athlete’s heart is characterized by similar LV
and RV hypertrophy.
METHODS The LV and RV mass, volume, and function in 21 male endurance athletes (A) (27 4 years;
70  8 kg; 178  7 cm; maximal oxygen uptake [VO2max]: 68  5 ml/min per kg) and 21
pair-matched untrained control subjects (C) (26  3 years; 71  9 kg; 178  6 cm; VO2max:
42  6 ml/min per kg) were analyzed by MRI (Magnetom Vision 1.5T, Siemens, Erlangen,
Germany).
RESULTS Left ventricular masses (A: 200  20 g; C: 148  17 g) and RV masses (A: 77  10 g; C:
56  8 g) differed significantly between the groups (p  0.001). The LV and RV
end-diastolic volumes (EDV) (LV-EDV 167  28 ml [A]; 125  16 ml [C]; RV-EDV 160
 26 ml [A]; 128  10 ml [C]), and stroke volumes (SV) (LV-SV: 99  18 ml [A], 74 
11 ml [C]; RV-SV: 102  18 ml [A], 79  8 ml [C]) were significantly different between
the athletes and control subjects (p  0.001), whereas ejection fractions (EF) (LV-EF: 59 
3% [A]; 59  6% [C]; RV-EF: 63  3% [A], 62  3% [C]) and LV-to-RV ratios were
similar for both groups (LV-to-RV mass: 2.6  0.2 [A], 2.6  0.3 [C]; LV-to-RV EDV:
1.05  0.14 [A], 0.99  0.14 [C]; LV-to-RV SV: 0.98  0.17 [A], 0.95  0.17 [C];
LV-to-RV EF: 0.93  0.07 [A], 0.96  0.10 [C]).
CONCLUSIONS Regular and extensive endurance training results in similar changes in LV and RV mass,
volume, and function in endurance athletes. This leads to the conclusion that the athlete’s
heart is a balanced enlarged heart. (J Am Coll Cardiol 2002;40:1856–63) © 2002 by the
American College of Cardiology Foundation
Regular and extensive endurance training leads to a cardiac
hypertrophy called athlete’s heart. It is assumed that the
dimensional changes affect all cardiac cavities to the same
extent, resulting in a balanced cardiac hypertrophy (1–3).
On the electrocardiogram (ECG), signs of left ventricular
(LV) or right ventricular (RV) hypertrophy, such as in-
creased R waves in the left precordial leads or an incomplete
right bundle branch block, can be found without evidence of
an athlete’s heart (1,2,4). In the past two decades, echocar-
diographic studies documented typical morphologic changes
in the LV, such as the increase in the inner end-diastolic
diameter (EDD), myocardial wall thickness, and myocardial
mass which correspond to eccentric hypertrophy (3,5–8). In
contrast, only limited data are available on the RV because
of its complex shape and pronounced trabecular structure,
which only allows an orientating echocardiographic analysis.
Maron (6) reported in a meta-analysis of 28 echocardio-
graphic studies of athletes’ hearts that the RV inner end-
diastolic diameter was determined in only 8 studies and that
it was 24% greater than that in normal individuals, whereas
the training-induced difference in the size of the LV
averaged only 10%.
By magnetic resonance imaging (MRI), it is now possible
to perform reliable determinations of both LV and RV mass
and volume (9–14). However, only a few MRI studies
examined the RV (9–16). A systematic study on the extent
of RV hypertrophy of the athlete’s heart has not been
performed so far. Therefore, it was the aim of this study to
compare the extent of LV and RV hypertrophy in male
endurance athletes with an athlete’s heart. It was hypothe-
sized that the ratios between LV and RV mass and volume
of the athlete’s heart and hearts of normal size would be
similar. This would prove the assumption that the athlete’s
heart represents a balanced cardiac hypertrophy.
METHODS
Study population. Twenty-one healthy, well-trained male
endurance athletes (10 tri-athletes, 6 cyclists, and 5 runners)
with a training history of many years and a control group of
21 healthy, untrained males pair-matched for height (max-
imal tolerated deviation 5 cm), weight (maximal tolerated
deviation 5 kg), and body surface area (BSA; maximal
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tolerated deviation 0.06 kg/m2) volunteered for the study
(Table 1). To meet the definition of athlete’s heart, endur-
ance athletes had to have a relative heart volume of at least
13 ml/kg, as determined by echocardiography (5) at the
time of the examination. To exclude cardiovascular and
other relevant diseases, each participant underwent a phys-
ical examination, including a determination of usual blood
parameters, blood pressure at rest, ECG at rest, and color
Doppler echocardiography. The study was approved by the
institutional Review Committee, and all participants gave
their written, informed consent.
Cardiopulmonary exercise test. Maximal oxygen uptake
(VO2max) was measured by indirect mixing-chamber spi-
rometry (Cortex MetaMax I, Leipzig, Germany). An indi-
vidually adjusted ramp protocol was chosen to exhaust
subjects within 10 to 12 min. Tri-athletes, cyclists, and
untrained control subjects were tested by cycle ergometry
(Lode Excalibur, Groningen, Netherlands), and long-
distance runners by treadmill ergometry (Woodway, Weil
am Rhein, Germany).
Echocardiography. Echocardiography was performed on a
GE System FiVe (GE, Vingmed Ultrasound, Horten,
Norway) with a 2.5-MHz transducer, in accordance with
the guidelines of the American Society of Echocardiography
(17). M-mode echocardiography was used to determine the
inner LV-EDD and RV-EDD, interventricular septal
thickness (IVST), posterior wall thickness (PWT), and
fractional shortening. Total LV-EDD (TEDD  LV-
EDD IVST PWT) was determined on the mitral valve
plane (TEDDM) and the papillary muscle plane (TEDDP).
Total LV longitudinal diameter (TLD) was determined in
the four-chamber-view. Parameters were measured three
times, and mean values were used to calculate the LV total
diastolic volume (TDV [ml]) and heart volume (HV [ml])
by the following formulae (5):
TDV([TEDDM20.785][TEDDP20.435])TLD/2000
HV(TDV2.432)130
Magnetic resonance imaging. The MRI was performed
on a 1.5-tesla magnet (Magnetom Vision, Siemens, Erlan-
gen, Germany). Images were acquired with the subject in
the supine position, by applying ECG-gated breath-hold
sequences. To get optimal image quality of myocardial
structures for evaluation of LV and RV mass, a T1-weighted
spin-echo sequence in the end-diastolic phase was used
(repetition time/echo time [TR/TE]  700/30 ms; flip
angle 160°, field of view 300 to 400 mm; matrix 256 256).
Ten to 14 oblique sagittal images perpendicular to the
ventricular septum (short-axis view) (Fig. 1) with a slice
thickness of 6 mm and an interslice gap of 4 mm were
acquired. To evaluate functional parameters, cine images
(TR/TE  100/4.8 ms; flip angle 20°) with the same
orientation as T1-weighted imaging were used for quanti-
fication of end-diastolic and end-systolic volumes (EDV
and ESV), covering the whole RR cycle in each slice with 14
to 22 images. For both sequences, the same slice positions
were used. Quantitative analysis was performed off-line
using dedicated software (ARGUS, Siemens). To evaluate
LV and RV mass and volume, manual tracing was used to
outline endocardial and epicardial borders.
The LV and RV volumes were determined as previously
described (13). If the pulmonic valve was seen at the RV
Abbreviations and Acronyms
BSA  body surface area
EDD  end-diastolic diameter
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Table 1. Anthropometric and Echocardiographic Data on Endurance Athletes and Untrained Control Subjects
Endurance Athletes
(n  21)
Untrained Control Subjects
(n  21) Difference
p
Value
Age (yrs) 27  5 (18–36) 26  3 (21–37) 2  7 NS
Weight (kg) 70  8 (53–85) 71  9 (55–88) 1  3 NS
Height (cm) 178  7 (165–190) 178  6 (164–186) 0  3 NS
BSA (m2) 1.87  0.14 (1.57–2.13) 1.88  0.14 (1.59–2.13) 0.01  0.30 NS
Body fat (%) 10.2  1.8 (7.4–12.5) 17.0  4.3 (9.1–26.0) 6.9  4.3 0.001
Lean body mass (kg) 63  6 (49–75) 59  6 (47–67) 4  3 0.001
VO2max (ml/min per kg) 68  5 (60–78) 42  6 (28–53) 26  8 0.001
Rest heart rate (beats/min) 53  6 (40–60) 66  8 (52–80) 13  11 0.001
LV-EDD* (mm) 56  3 (51–63) 50  3 (44–57) 6  3 0.001
IVST* (mm) 11.4  0.9 (10.0–13.0) 10.2  0.9 (7.5–11.5) 1.1  1.3 0.001
PWT* (mm) 11.2  0.9 (9.0–12.5) 9.5  0.9 (7.0–11.0) 1.4  1.3 0.001
FS* (%) 35  5 (25–46) 37  5 (26–45) 3  6 NS
RV-EDD* (mm) 26  3 (20–31) 22  4 (12–29) 4  6 0.05
Heart volume* (ml/kg) 14.5  1.0 (13.1–16.5) 11.1  0.6 (9.5–12.6) 3.5  1.2 0.001
*Parameters determined by echocardiography. Data are presented as the mean value  SD (range).
BSA  body surface area; FS  fractional shortening; IVST  interventricular septal thickness; LV-EDD  inner left ventricular end-diastolic diameter; PWT  posterior
wall thickness; RV-EDD  inner right ventricular end-diastolic diameter; VO2max  maximal oxygen uptake.
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volume, the portion above the valve as well as the right atrial
volumes were excluded. At the base of the LV, the aorta was
included in the LV volume below the aortic valve. Blood
volumes above the aortic valve, as well as volumes sur-
rounded by a thin myocardial wall on the mitral valve plane
(left atrial blood volume), were excluded from the LV
volume. By inspection of the cine loops, end-systole was
defined as the frame with the smallest ventricular cavity.
The LV-ESV and RV-ESV included aortic and pulmonary
outflow tract volumes below the valves. Atrial portions were
excluded. To differentiate papillary muscles from the wall in
end-systole, cine loops were inspected, and the grayscale was
adjusted so that variations near the endocardial border could
be seen.
The EDV and ESV were used to determine stroke
volume (SV), ejection fraction (EF), cardiac output, and
cardiac index. The LV and RV mass was determined by
summation of EDVs within the epicardial and endocardial
borders of the short-axis slices and multiplying the myocar-
dial tissue volume by its specific density of 1.05 gcm3:
Myocardial mass  1.05  
slices
thk  Aepi Aendo
where thk represents layer thickness (10 mm); Aepi repre-
sents epicardial area; and Aendo  endocardial area.
Epicardial fat and the pericardium were excluded from
RV and LV mass. Determination of LV mass included the
septum, but in contrast to Lorenz et al. (13), the papillary
muscles were excluded from LV mass analysis to avoid
relevant partial volume effects and therefore were added to
the LV volume (18,19). The RV free wall was used to
determine RV mass, according to the recommendations of
Cutrone et al. (12).
Statistical analysis. Normality was tested by the
Kolmogorov-Smirnov test, and differences between endur-
ance athletes and control subjects were measured by the
paired t test. Pearson correlation coefficients were calculated
for selected variables. Data are expressed as the mean value
 SD. An alpha error level of p  0.05 was considered as
statistically significant.
RESULTS
Ventricular mass. The LV and RV masses are presented in
Figure 2. The LV and RV masses were significantly
increased in endurance athletes (A) by 36  14% and 37 
17%, respectively, compared with untrained control subjects
(C). In addition, the indexed LV and RV masses (values
divided by BSA) showed similar differences. The ratio of
LV-to-RV mass was equal for athletes and control subjects
(Fig. 2). The LV and RV masses correlated significantly
with VO2max (r  0.89 and 0.85, respectively) (Fig. 3).
Ventricular volume. A significant correlation between
LV-EDV and RV-EDV was found (r  0.76; SEE  21
ml [LV-EDV  0.91  RV-EDV  16]; p  0.001). The
LV-EDV and RV-EDV values are shown in Figure 4. In
athletes, LV-EDV and RV-EDV were significantly greater
by 34  22% and 25  19%, respectively, compared with
control subjects. Indexed LV-EDV and RV-EDV values
showed similar differences. The LV-EDV-to-RV-EDV
Figure 1. End-diastolic T1-weighted short-axis slice from an endurance athlete (left) and an untrained control subject (right). Compared with the heart
of the control subject, the endurance athlete’s heart is characterized by an enlarged volume and a greater myocardial mass of both ventricles, while the
proportions of the left and right heart are the same as in the untrained control subject.
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Figure 2. Myocardial mass, myocardial mass index (myocardial mass divided by body surface area) and ratio of left ventricular (LV) to right ventricular (RV)
mass (ratio LVM/RVM) in endurance athletes (A) and untrained control subjects (C). Data are expressed as the mean value  SD. Error bars represent
95% confidence intervals. ***p  0.001 (paired t test).
Figure 3. Correlation of left ventricular mass (LVM) and right ventricular mass (RVM) to maximal oxygen uptake (VO2max).
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ratio did not differ between athletes and control subjects
(Fig. 4).
The LV-ESV and RV-ESV and indexed ESVs were also
significantly different between athletes and control subjects (p
 0.001): LV-ESV 68  11 ml (A) and 51  10 ml (C);
indexed LV-ESV 36.3  4.5 ml/m2 (A) and 27.1  4.6
Figure 4. End-diastolic volume, end-diastolic volume index (end-diastolic volume divided by body surface area) and ratio of left ventricular (LV) to right
ventricular (RV) end-diastolic volume (EDV) (ratio LV-EDV/RV-EDV) in endurance athletes (A) and untrained control subjects (C). Data are expressed
as the mean value  SD. Error bars represent 95% confidence intervals. ***p  0.001 (paired t test).
Figure 5. Stroke volume, ejection fraction (EF), ratio of left ventricular (LV) to right ventricular (RV) stroke volume (ratio stroke volume LV/RV), and
ratio of LV-EF to RV-EF (ratio EF LV/RV) in endurance athletes (A) and untrained control subjects (C). Data are expressed as the mean value  SD.
Error bars represent 95% confidence intervals. **p  0.01 and ***p  0.001 (paired t test).
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ml/m2 (C); RV-ESV 58  10 ml (A) and 49  4 ml (C);
indexed RV-ESV 31.1  4.5 ml/m2 (A) and 26.1  2.6
ml/m2 (C).
Functional parameters. Stroke volumes, EFs, and ratios
are presented in Figure 5. In athletes, the LV-SV and
RV-SV were significantly higher by 34  22% and 29 
19%, respectively, compared with control subjects. Indexed
LV-SV and RV-SV showed similar differences. The
LV-EF and RV-EF did not show a significant difference
between athletes and control subjects. However, in athletes,
a small but significantly higher RV-EF than LV-EF was
noted (p  0.01). The LV-SV–to–RV-SV ratio, as well as
the LV-EF–to–RV-EF ratio, did not differ between ath-
letes and control subjects.
There were no significant differences between athletes
and control subjects for cardiac output at rest (A: 5.2  0.9
and C: 4.9  0.9 l/min) and cardiac index at rest (A: 2.8 
0.4 and C: 2.6  0.5 l/min per m2).
DISCUSSION
Although some previous MRI studies analyzed RV mass
and function (9–16), studies on endurance athletes with an
athlete’s heart have not been performed so far. Previous
studies were either used to evaluate the method’s precision
and reproducibility (9,11,12,14) or to examine pathologic
alterations of the right heart (10,16). None of these studies
differentiated between healthy, untrained subjects and
endurance-trained athletes. To our knowledge, this is the
first MRI study to evaluate changes in the RV in endurance
athletes with an athlete’s heart.
Ventricular mass. An LV mass of 115 to 189 g, and
normalized to a BSA, an LV mass of 69 to 96 g/m2, have
been reported in healthy subjects in previous MRI studies
(18,20–22). In the present study, the LV mass was 148 g
and 79 g/m2 in healthy, untrained control subjects, which is
between the reported extreme values. The wide range of
extreme values determined in previous MRI studies can be
explained by: 1) gender differences and study populations
with indiscernible quotas of female subjects; 2) different
fitness levels and heart volumes of studied subjects; and 3)
methodologic differences in the off-line image analysis. In
the present study, papillary muscles were excluded from LV
mass analysis, as in earlier studies (18,19), in order to avoid
relevant partial volume effects and to allow a better com-
parison with echocardiographic studies.
For LV hypertrophy, M-mode echocardiographic studies
determined an upper clinical limit for LV mass and indexed
mass from 215 to 259 g and 125 to 131 g/m2, respectively,
which causes an increase in cardiovascular mortality if
exceeded (23–26). In autopsy studies, upper limits from 184
to 204 g were determined (27–30). In a recent MRI study,
238 g and 113 g/m2 were reported (13). In the present
study, the LV mass of endurance athletes averaged 200 g
and 107 g/m2, which was in the upper range of limit values
determined by autopsy and MRI studies. Some individual
values exceeded predetermined limit values; however, this
extent of hypertrophy is still physiologic and a well-
documented phenomenon (2,3,5,7,8). In addition, the LV
mass of endurance athletes was very similar to that reported
earlier in cyclists (200 g and 102 g/m2) (18). Higher values
reported in other studies (20,31) may be due to aforemen-
tioned methodologic differences.
The present RV mass of 56 g in untrained, healthy males
was in the upper normal range compared with those values
found in previous studies. In other MRI studies, RV mass
ranging from 42 to 53 g has been observed in healthy
subjects (10–13,15,16). The MRI study with the greatest
number of subjects averaged 50 g for RV mass (13) in
healthy males. In two computed tomographic studies, RV
mass was 54 and 55 g (12,32). In autopsy studies, RV mass
ranged from 46 to 58 g (12,27–30), and it was 56 g in males
of “average weight” (28,30), which is similar to the present
results.
In only two studies, RV mass was normalized to BSA
(10,13). In the present study, the indexed RV mass of
healthy, untrained males, was slightly higher than that
previously reported by Lorenz et al. (13) (26 g/m2). This
small difference may be attributed to methodologic differ-
ences. In contrast to Lorenz et al. (13), instead of a cine
sequence, we used a T1-weighted sequence to more pre-
cisely depict RV trabeculae, as described by Cutrone et al.
(12) for RV mass determination. The lower indexed RV
mass found by Katz et al. (10) (26 g/m2), as well as the lower
absolute RV masses found in other studies, are most easily
attributed to an unknown number of female subjects eval-
uated (11,12,15,27).
The upper clinical limit of RV mass and indexed mass
determined by MRI has been reported to be 70 g and 36
g/m2, respectively (13). In autopsy studies, the upper clinical
limit of RV mass was between 65 and 79 g (27–30). The
mean values of 77 g and 41 g/m2 of the endurance athletes
in this study were within the range of the upper clinical
limits and, analogous to LV mass, exceeded these limits in
individual cases. Comparable MRI data on the RV in
athletes do not exist. The present results suggest that
endurance training induces not only LV hypertrophy but
also RV hypertrophy and therefore also represents a phys-
iologic adaptation.
The LV-to-RV mass ratio in both groups in this study
was 2.6, which is almost identical to the results of the two
major autopsy studies that determined a normal range from
2.3 to 3.3 (mean 2.7) and 2.1 to 3.6 (mean 2.7), respectively
(27,28). However, most important was the finding that
normal, healthy subjects and endurance athletes have iden-
tical LV-to-RV mass ratios, representing a balanced biven-
tricular hypertrophy in the athlete’s heart. This balanced
biventricular hypertrophy is also reinforced by the close
correlations of LV and RV mass to VO2max.
Because valid data on the RV of the athlete’s heart have not
been available so far, the extent of RV hypertrophy has
primarily been a matter of speculation. The high prevalence of
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an incomplete right bundle branch block, as well as early
echocardiographic studies in athletes have led to the assump-
tion that hypertrophy of the athlete’s heart might be especially
related to the RV (2,4,6). Now, for the first time, the real
extent of RV hypertrophy in the athlete’s heart has been
demonstrated.
Ventricular volume. The LV- and RV-EDV and -ESV of
control subjects were similar to those values reported in the
literature (9,11,13,14,18,20–22,31,33–35). According to
previous results, a close matching between RV-EDV and
LV-EDV was found (11,14,16). In two studies in which the
RV-EDV was higher than the LV-EDV, a different meth-
odology (9) and partial volume effects of the papillary
muscles (9,13) may have led to an underestimation of the
LV-EDV.
In the present study, endurance athletes showed greater
EDV and ESV of both ventricles. In addition, the similar
ratio of LV-EDV to RV-EDV in both groups indicates that
endurance training induces both, a balanced biventricular
myocardial hypertrophy and a balanced biventricular dila-
tion.
The fact that these endurance athletes showed normal
cardiac enlargement is in agreement with previous MRI
studies (20,31,35). Only in one study of cyclists, there was
evidence of a much larger LV-EDV (222 ml and 112
ml/m2) (18). However, because the LV-EDV of healthy
control subjects was also clearly higher in this previous study
(184 ml and 93 ml/m2) (18), it seems possible that parts of
the LV outflow tract above the semilunar valves and/or parts
of the left atrium were added to the LV volume.
Functional parameters. For control subjects and endur-
ance athletes, SVs and EFs tended to be somewhat lower
than those in the literature (9,11,13,21,22,31,33,35). This
could be explained by a more difficult outlining of the
papillary muscles in end systole, with a minor overestima-
tion of ESV. Compared with untrained control subjects, the
higher LV-SV and RV-SV of endurance athletes is due to
a greater EDV of hypertrophied ventricles and not to a
higher EF.
Noninvasive studies, in particular, echocardiographic
studies, have shown that LV systolic function remains
unchanged in the athlete’s heart (2,3,6,8). These observa-
tions were confirmed in the present study, and in addition
are now documented in the RV by the present MRI data.
Furthermore, for both study groups, the MRI-derived
cardiac output at rest of 	5 l/min also corresponds to that
of earlier studies (2,13,31,35).
Study limitations. In addition to a cine sequence for
volume determination, a spin-echo sequence was used to get
optimal image quality for mass determination, which may
have caused some overlap, albeit small, in the measurement
of mass and volume. Furthermore, the findings of the
present study do not apply to female endurance athletes.
Conclusions. The findings of physiologic LV hypertrophy
induced by regular and extensive endurance training in
previous echocardiographic and MRI studies can be con-
firmed by the present MRI study. In addition, for the first
time, the extent of physiologic RV hypertrophy, including
anatomic and functional parameters of the athlete’s heart,
was evaluated by MRI. Thus, it was possible to demonstrate
that regular and extensive endurance training results in
similar changes of LV and RV mass, volume, and function,
as demonstrated by the constant ratios of the determined
parameters. Therefore, the athlete’s heart is a balanced
enlarged heart.
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